Answers to the other important questions:
How did tiredness levels compare between the 2 treatments?
Patients in both treatment groups reported feeling less tired.
The improvement in tiredness levels was similar between the
2 treatments.
What percentage of patients in each treatment group had
breakthrough hemolysis™
RAVULIZUMAB ECULIZUMAB
' 5 out of 125 patients @ - 13 out of 121 patients @
5 out of 125 patients (4%) had breakthrough 13 out of 121 patients (11%) had breakthrough
hemolysis. The earliest it happened was hemolysis. The earliest it happened was
around 10 weeks into treatment. around 6 weeks into treatment.
*Breakthrough hemolysis means an increase in LDH levels and a new or worsening symptom or a serious complication
What percentage of patients in each treatment group had stable
hemoglobin levels?
During hemolysis, the destruction of the red blood cells causes the release of hemoglobin, which is
then free to enter the bloodstream. Free hemoglobin can lead to serious health problems, such as
blood clots and damage to organs. The researchers checked each patient's hemoglobin level during
the study to see if it remained stable on treatment.
RAVULIZUMAB ECULIZUMAB
EE —O ae Ó
The results were similar between treatment groups. 68% of patients who got ravulizumab had
stable hemoglobin levels compared to 65% of patients who got eculizumab.
y Protocol, ALXN1210-PNH-301 SPONSOR CONTACT INFORMATION
LEXION Europe, 2016-002025-11 1-888-765-4747
6 CertarUSaA Inc. 2020. Allights reserved United States, NCT02946463 medinfo@alexion.com 7